Literature DB >> 11517243

Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons.

M Li1, D A Linseman, M P Allen, M K Meintzer, X Wang, T Laessig, M E Wierman, K A Heidenreich.   

Abstract

Myocyte enhancer factor 2 (MEF2) proteins are important regulators of gene expression during the development of skeletal, cardiac, and smooth muscle. MEF2 proteins are also present in brain and recently have been implicated in neuronal survival and differentiation. In this study we examined the cellular mechanisms regulating the activity of MEF2s during apoptosis of cultured cerebellar granule neurons, an established in vitro model for studying depolarization-dependent neuronal survival. All four MEF2 isoforms (A, B, C, and D) were detected by immunoblot analysis in cerebellar granule neurons. Endogenous MEF2A and MEF2D, but not MEF2B or MEF2C, were phosphorylated with the induction of apoptosis. The putative sites that were phosphorylated during apoptosis are functionally distinct from those previously reported to enhance MEF2 transcription. The increased phosphorylation of MEF2A and MEF2D was followed by decreased DNA binding, reduced transcriptional activity, and caspase-dependent cleavage to fragments containing N-terminal DNA binding domains and C-terminal transactivation domains. Expression of the highly homologous N terminus of MEF2A (1-131 amino acids) antagonized the transcriptional activity and prosurvival effects of a constitutively active mutant of MEF2D (MEF2D-VP16). We conclude that MEF2A and MEF2D are prosurvival factors with high transcriptional activity in postmitotic cerebellar granule neurons. When these neurons are induced to undergo apoptosis by lowering extracellular potassium, MEF2A and MEF2D are phosphorylated, followed by decreased DNA binding and cleavage by a caspase-sensitive pathway to N-terminal fragments lacking the transactivation domains. The degradation of MEF2D and MEF2A and the generation of MEF2 fragments that have the potential to act as dominant-inactive transcription factors lead to apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517243      PMCID: PMC6763101     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  33 in total

1.  Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.

Authors:  M Li; X Wang; M K Meintzer; T Laessig; M J Birnbaum; K A Heidenreich
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.

Authors:  J Lu; T A McKinsey; R L Nicol; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

3.  Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2.

Authors:  H D Youn; L Sun; R Prywes; J O Liu
Journal:  Science       Date:  1999-10-22       Impact factor: 47.728

4.  Regulatory role of MEF2D in serum induction of the c-jun promoter.

Authors:  T H Han; R Prywes
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

5.  Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP.

Authors:  S R D'Mello; C Galli; T Ciotti; P Calissano
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

6.  Myocyte enhancer factor 2C upregulates MASH-1 expression and induces neurogenesis in P19 cells.

Authors:  I S Skerjanc; S Wilton
Journal:  FEBS Lett       Date:  2000-04-21       Impact factor: 4.124

7.  Post-translational control of the MEF2A transcriptional regulatory protein.

Authors:  O I Ornatsky; D M Cox; P Tangirala; J J Andreucci; Z A Quinn; J L Wrana; R Prywes; Y T Yu; J C McDermott
Journal:  Nucleic Acids Res       Date:  1999-07-01       Impact factor: 16.971

8.  HDAC4 deacetylase associates with and represses the MEF2 transcription factor.

Authors:  E A Miska; C Karlsson; E Langley; S J Nielsen; J Pines; T Kouzarides
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

9.  Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle.

Authors:  S L Amacher; J N Buskin; S D Hauschka
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

10.  Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1.

Authors:  C C Yang; O I Ornatsky; J C McDermott; T F Cruz; C A Prody
Journal:  Nucleic Acids Res       Date:  1998-10-15       Impact factor: 16.971

View more
  49 in total

1.  Inhibition of the cdk5/MEF2 pathway is involved in the antiapoptotic properties of calpain inhibitors in cerebellar neurons.

Authors:  Ester Verdaguer; Daniel Alvira; Andrés Jiménez; Victor Rimbau; Antoni Camins; Mercè Pallàs
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

2.  Inhibition of Rac GTPase triggers a c-Jun- and Bim-dependent mitochondrial apoptotic cascade in cerebellar granule neurons.

Authors:  Shoshona S Le; F Alexandra Loucks; Hiroshi Udo; Sarah Richardson-Burns; Reid A Phelps; Ron J Bouchard; Holger Barth; Klaus Aktories; Kenneth L Tyler; Eric R Kandel; Kim A Heidenreich; Daniel A Linseman
Journal:  J Neurochem       Date:  2005-08       Impact factor: 5.372

3.  Neuronal Myocyte-Specific Enhancer Factor 2D (MEF2D) Is Required for Normal Circadian and Sleep Behavior in Mice.

Authors:  Jennifer A Mohawk; Kimberly H Cox; Makito Sato; Seung-Hee Yoo; Masashi Yanagisawa; Eric N Olson; Joseph S Takahashi
Journal:  J Neurosci       Date:  2019-08-16       Impact factor: 6.167

4.  KIN-29 SIK regulates chemoreceptor gene expression via an MEF2 transcription factor and a class II HDAC.

Authors:  Alexander M van der Linden; Katherine M Nolan; Piali Sengupta
Journal:  EMBO J       Date:  2006-12-14       Impact factor: 11.598

5.  Analysis of gene expression during aging of CGNs in culture: implication of SLIT2 and NPY in senescence.

Authors:  K Preeti Gupta; Pankaj Singh Dholaniya; Anil Chekuri; Anand K Kondapi
Journal:  Age (Dordr)       Date:  2015-06-06

6.  Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency.

Authors:  Helen Bryant; Paul J Farrell
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Oxidation of survival factor MEF2D in neuronal death and Parkinson's disease.

Authors:  Li Gao; Hua She; Wenming Li; Jin Zeng; Jinqiu Zhu; Dean P Jones; Zixu Mao; Guodong Gao; Qian Yang
Journal:  Antioxid Redox Signal       Date:  2014-02-03       Impact factor: 8.401

8.  Undermining the endothelium by ablation of MAPK-MEF2 signaling.

Authors:  Eric N Olson
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 9.  Class IIA HDACs in the regulation of neurodegeneration.

Authors:  Nazanin Majdzadeh; Brad E Morrison; Santosh R D'Mello
Journal:  Front Biosci       Date:  2008-01-01

10.  Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis.

Authors:  Gabriela Paroni; Michela Mizzau; Clare Henderson; Giannino Del Sal; Claudio Schneider; Claudio Brancolini
Journal:  Mol Biol Cell       Date:  2004-04-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.